Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China

Author:

He Yutong1,Liang Di1,Du Lingbin2,Guo Tiantian1,Liu Yanyu1,Sun Xibin3,Wang Ning4,Zhang Min5,Wei Kuangrong6,Shan Baoen1,Chen Wanqing7

Affiliation:

1. Cancer Institute the Fourth Hospital of Hebei Medical University/the Tumor Hospital of Hebei Province Shijiazhuang Hebei 050000 P. R. China

2. Zhejiang Cancer Center Hangzhou Zhejiang 310000 P. R. China

3. Henan Cancer Hospital Zhengzhou Henan 450000 P. R. China

4. Beijing Cancer Hospital Beijing 100021 P. R. China

5. Hubei Cancer Hospital Wuhan Hubei 430000 P. R. China

6. Zhongshan Cancer Hospital Zhongshan Guangdong 528400 P. R. China

7. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Science & Peking Union Medical College Beijing 100021 P. R. China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer incidence and mortality in China, 2014;Chen W SK;Chin J Cancer Res,2018

3. Epidemiology of Esophageal Cancer in Japan and China

4. Epidemiological features of esophageal cancer. Squamous cell carcinoma versus adenocarcinoma

5. Long‐Term Oncologic Outcomes, Opioid Use, and Complications after Esophageal Cancer Surgery;Oh TK;J Clin Med,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3